Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Moretta

Showing results (141-150 of 205) with videos related to

Pageof 21
Sort By:
Best Practice & Research. Clinical Haematology|September 20, 2011
Strategies to optimize the outcome of children given T-cell depleted HLA-haploidentical hematopoietic stem cell transplantationFranco Locatelli, Luciana Vinti, Giuseppe Palumbo, et al.
Plos One|December 10, 2009
Susceptibility of human melanoma cells to autologous natural killer (NK) cell killing: HLA-related effector mechanisms and role of unlicensed NK cellsPaolo Carrega, Gaetana Pezzino, Paola Queirolo, et al.
Oncoimmunology|February 7, 2019
PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expressionFrancesca R Mariotti, Stefania Petrini, Tiziano Ingegnere, et al.
The Journal of Clinical Investigation|November 20, 2002
IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanismKarl-Johan Malmberg, Victor Levitsky, Håkan Norell, et al.
Journal of Autoimmunity|May 10, 2016
Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosisAlice Laroni, Eric Armentani, Nicole Kerlero de Rosbo, et al.
Journal of Immunology Research|June 14, 2016
NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?Claudia Cantoni, Leticia Huergo-Zapico, Monica Parodi, et al.
Oncotarget|May 1, 2017
NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27Alessandra Dondero, Beatrice Casu, Francesca Bellora, et al.
Blood|January 5, 2007
The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissuesSilvia Parolini, Amerigo Santoro, Emanuela Marcenaro, et al.
The Pediatric Infectious Disease Journal|December 25, 2008
Multiple relapses of visceral leishmaniasis in an adolescent with idiopathic CD4+ lymphocytopenia associated with novel immunophenotypic and molecular featuresIgnazia Prigione, Elio Castagnola, Luisa Imberti, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 18, 2004
Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysisRoberta Castriconi, Alessandra Dondero, Raffaella Augugliaro, et al.
Pageof 21

Showing results (141-150 of 205) with videos related to

Sort By:
Pageof 21
Best Practice & Research. Clinical Haematology|September 20, 2011
Strategies to optimize the outcome of children given T-cell depleted HLA-haploidentical hematopoietic stem cell transplantationFranco Locatelli, Luciana Vinti, Giuseppe Palumbo, et al.
Plos One|December 10, 2009
Susceptibility of human melanoma cells to autologous natural killer (NK) cell killing: HLA-related effector mechanisms and role of unlicensed NK cellsPaolo Carrega, Gaetana Pezzino, Paola Queirolo, et al.
Oncoimmunology|February 7, 2019
PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expressionFrancesca R Mariotti, Stefania Petrini, Tiziano Ingegnere, et al.
The Journal of Clinical Investigation|November 20, 2002
IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanismKarl-Johan Malmberg, Victor Levitsky, Håkan Norell, et al.
Journal of Autoimmunity|May 10, 2016
Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosisAlice Laroni, Eric Armentani, Nicole Kerlero de Rosbo, et al.
Journal of Immunology Research|June 14, 2016
NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?Claudia Cantoni, Leticia Huergo-Zapico, Monica Parodi, et al.
Oncotarget|May 1, 2017
NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27Alessandra Dondero, Beatrice Casu, Francesca Bellora, et al.
Blood|January 5, 2007
The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissuesSilvia Parolini, Amerigo Santoro, Emanuela Marcenaro, et al.
The Pediatric Infectious Disease Journal|December 25, 2008
Multiple relapses of visceral leishmaniasis in an adolescent with idiopathic CD4+ lymphocytopenia associated with novel immunophenotypic and molecular featuresIgnazia Prigione, Elio Castagnola, Luisa Imberti, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 18, 2004
Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysisRoberta Castriconi, Alessandra Dondero, Raffaella Augugliaro, et al.
Pageof 21